Pentec Health compounds patient specific, Intradialytic Parenteral Nutrition (IDPN) and Intraperitoneal Nutrition (IPN) therapies that are custom prepared to meet the individual needs of each patient. Over the past three decades, we have earned the trust of nephrologists nationwide through our therapy that supports nutritional needs for patients who exhibit protein malnutrition.

In 2008, with a thorough understanding of many unmet needs for protein malnourished HD patients, our nationally recognized expert in IDPN worked to solve the tolerance issues associated with this therapy. Through her experience and discussions with clinicians, she recognized that the essential issue was composition problems inherent in traditional IDPN solutions, which caused many side effects including nausea, vomiting and chills. Her experience and expertise lead to the creation of newer, better tolerated IDPN solutions for malnourished hemodialysis patients.
The introduction of the Proplete family of IDPN and IPN therapy was the shift in paradigm that patients and clinicians needed. With dextrose greatly reduced and lipid removed with adequate protein provision maintained, these new weight-based solutions had several advantages for both patients and the RN administering them.